Is CRESY or HHS more undervalued in 2026?

CirclFi compares Cresud S.A.C.I.F. y A. (CRESY) and Harte Hanks, Inc. (HHS) using 13 institutional-grade valuation models. CRESY has a Quality of Company score of 2.0/10 while HHS scores 6.0/10.

Which is a better buy — CRESY or HHS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CRESY and HHS valuations compare?

CRESY at $11.86 and HHS at $2.58 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CRESY vs HHS Valuation Comparison 2026 — Intrinsic Value Analysis

CRESY

Conglomerates

Cresud S.A.C.I.F. y A.

Quality

2.0

out of 10

Value Trap

—

Price

$11.86

Last close

Models

6/13

Active

HHS

Conglomerates

Harte Hanks, Inc.

Quality

6.0

out of 10

Value Trap

SAFE

Price

$2.58

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	CRESY Fair Value	CRESY Upside	HHS Fair Value	HHS Upside
Bayesian DCF	Intrinsic	$3.14	-73.5%	$10.97	+325.4%
Earnings Power Value	Intrinsic	—	—	$4.57	+77.1%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$69.03	+482.0%	—	—
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CRESY vs HHS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CRESY vs HHS — Which Stock Is More Undervalued?

HHS scores higher with a 6.0/10 quality rating vs CRESY's 2.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cresud S.A.C.I.F. y A. (CRESY) and Harte Hanks, Inc. (HHS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CRESY currently trades at $11.86 with a QOC of 2.0/10, while HHS trades at $2.58 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).